Weill Cornell Medicine’s Clinical and Translational Science Center received a $45.3 million renewal of its funding from the National Institutes of Health through 2022. The center, which supports translating research into treatments for patients, is a consortium that includes participation from NewYork-Presbyterian Hospital, Cornell University, Memorial Sloan Kettering Cancer Center, Hospital for Special Surgery, CUNY Hunter College and Animal Medical Center.